Value in Health: Defining a Core Data Set for the Economic Evaluation of Precision Oncology
Despite the growing abundance of multiomic data in precision oncology, the lack of standardization and interoperability impedes economic evaluation. In the latest issue of Value in Health, Samantha Pollard, PhD et al. found significant variability in published data resources. Through their work, they identified a core set of 68 data elements that they believe would support accurate and efficient economic evaluations.
PM Live Interview: Improving Drug Access with Data Analytics – Earlene Biggs, VP of Market Research and Analytics at ICON
Accurate and insightful market research is essential to successfully bring therapeutics from the drawing board to patients. In a new [...]
Cytel Announces Free Statistical Programming Ebook
When submitting data to the US Food and Drug Administration, maintaining a steady line of communications is essential. Frequent [...]
ISPOR 2022: New Analytical Approaches to 21st Century Challenges
As the world becomes increasingly smaller, standard economic models are straining to predict or explain how global systems. In a [...]
Inovalon Launches Saas Solution for Converged Risk Assessment and Quality Measurement Analytics
Inovalon has announced the launch of the industry's first Saas solution for risk adjustment analytics and quality measurement analytics, Inovalon [...]
Case Study: MMIT’s Analytics Platform Saves Time and Resources for Healthcare Services Company
MMIT has released a case report detailing how its MMIT Analytics platform helped one healthcare services company save time and [...]
Healthcare Business Transformation Consortium Launched to Promote Real-Time Analytics for Healthcare Management
SAP and Intel have partnered to launch the Healthcare Business Transformation Consortium (HBTC) to help healthcare systems implement real-time analytics [...]
Webinar: Cost-effectiveness of R vs. Excel in Health Technology Assessments
On Wednesday, December 15th at 12:OOPM EST, Jeroen Jansen, Petros Pechlivanoglou, and Howard Thom will present a webinar examining the [...]
Now Available: Economic & Related Consulting Service Revenues WORLD REPORT + DATABASE
Research and Markets has released their Economic & Related Consulting Service Revenues World Report + Database, which covers products and [...]
MMIT and Evaluate Acquire Panalgo to Streamline RWE and Ultimately Improve Patient Outcomes
Managed Markets Insight & Technology (MMIT) and Evaluate announced their acquisition of healthcare analytics company Panalgo. This acquisition will streamline [...]
FDA Launches Rare Disease Cures Accelerator-Data and Analytics Platform
Funded by the Food and Drug Administration, the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) has just been launched. [...]
Assigning Value to Cell and Gene Therapies With Analytics
A whitepaper from MMIT provides information on value assessments and insight into market access for gene and cell-based therapies. MMIT [...]
COVID-19 Pandemic Brings Far-reaching Healthcare Consequences and Increased Disease Risk
A new whitepaper discusses how deferred care or a lack of care during the pandemic will drive high healthcare costs [...]
Using Analytics to Understand Value-Based Pricing During COVID-19
Value-based prescription drug pricing agreements are increasing for many expensive and complex drugs. However, these agreements are becoming less used [...]
Storage a Major Challenge in Genomics Tools for Precision Medicine
Genomics tools are driving progress in precision medicine. These tools, such as next generation sequencing (NGS) technologies, allow for large [...]
Pricing Experts Offer Insight Into Use of Advanced Analytics, Note 85% of Companies Lack Sufficient Data or Detailed Pricing Information
85% of interviewed companies lack sufficient data, price quality, or price transparency information to be able to properly apply advanced [...]
Webinar on RWE and Progress During COVID-19 Pandemic
The COVID-19 Pandemic has driven many researchers to incorporate RWE (real world evidence) into clinical trials. However, it can often [...]
Using Bayesian Methods in Control Arms of Clinical Trials
The use of single arm trials has become more widespread, especially as the COVID-19 has forced clinical trials to change [...]
[Whitepaper] Understanding and Using SDOH Data
SDOH (social determinants of health) data can be incredibly valuable. While these data can be immensely useful in reducing medical [...]
Understanding Machine Learning Tools that Will Impact Healthcare
Predictive machine learning tools are expected to help healthcare payers and providers make cost-effective choices. However, despite being powerful tools, [...]
Bayesian Models are Underused yet Powerful Tools
In a recent study, Cytel researchers discussed the benefits of Bayesian models. They’re a good choice for both single arm [...]
3 Ways That Payers Leveraged Artificial Intelligence in 2020
Payers used artificial intelligence to drive towards key objectives in 2020. Artificial intelligence is not a new technology, with the [...]
Cerner Aspires to Build $1B Data Business in Pharma Market
Building on its acquisition of clinical research company Kantar Health, health IT giant Cerner is setting its sights on building [...]
Read Up On How Regulators Are Using RWE
RWE is playing a growing role in FDA approvals. According to an Aetion analysis, 49 percent of submissions for new drugs [...]
Panalgo’s IHD Platform to Be Used by the EU Medicines Agency for Real-World Data Analytics
Panalgo, a leading healthcare analytics company, today announced that its Instant Health Data (IHD) platform will be used by the European Medicines Agency (EMA) to [...]